CORE LABORATORIES N.V. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2018-10-24: Form 8-K; Period of report 2018-10-24; Description 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 2.02.
- 2018-10-09: Form 8-K; Period of report 2018-10-09; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2018-10-04: Form 8-K; Period of report 2018-10-04; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2018-07-25: Form 8-K; Period of report 2018-07-25; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2018-10-24 | 8-K | 2018-10-24 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2.02 On October 24, 2018, Core Laboratories N.V. (the "Company") issued a press release announcing its financial results for the third quarter of 2018. 5.02 On October 24, 2018, the Company announced that, effective December 31, 2018, Monty L. Davis will retire from the Company, and therefore his role as Chief Operating Officer and Senior Vice President. | clb-2018q3_earningsrelease.htm |
| 2018-10-09 | 8-K | 2018-10-09 | 7.01 Regulation FD Disclosure | 7.01 On October 9, 2018, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on October 19, 2018 and payable November 20, 2018. | clb-8k_dividend4q2018.htm |
| 2018-10-04 | 8-K | 2018-10-04 | 7.01 Regulation FD Disclosure | 7.01 Core Laboratories N.V. announces that Gwen Schreffler, SVP Corporate Development and Investor Relations and Richard Leonard, Director of Global Technology, Production Enhancement will participate in the Oil Services Panel at the Wolfe Research Utilities and Energy Conference in New York City on Thursday, October 4, 2018. | a8-kclbqaoctx18.htm |
| 2018-07-25 | 8-K | 2018-07-25 | 2.02 Results of Operations and Financial Condition | 2.02 On July 25, 2018, Core Laboratories N.V. issued a press release announcing its financial results for the second quarter of 2018. | clb-2018q2_earningsrelease.htm |
| 2018-07-13 | 8-K | 2018-07-13 | 7.01 Regulation FD Disclosure | 7.01 On July 13, 2018, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on July 23, 2018 and payable August 13, 2018. | clb-8k_dividend3q2018.htm |
| 2018-06-29 | 8-K | 2018-06-29 | 7.01 Regulation FD Disclosure | 7.01 On June 29, 2018, Core Laboratories N.V. issued a press release announcing: (1) revisions to previously issued earnings guidance for its second quarter 2018 and (2) initiating earnings guidance for third quarter 2018. | a8-kq22018earningsguidance.htm |
| 2018-06-28 | 8-K/A | 2018-06-28 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into Material Definitive Agreement. 2.03 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. | q220188-kadebtagreement.htm |
| 2018-06-25 | 8-K | 2018-06-25 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into Material Definitive Agreement. 5.02 On January 31, 2018, the Company announced that, effective May 24, 2018, Christopher Hill would replace Richard Bergmark as Chief Financial Officer. | a8k_clb-debtannouncement61.htm |
| 2018-05-29 | 8-K | 2018-05-24 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 Core Laboratories N.V. (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting") on May 24, 2018 in Amsterdam, The Netherlands. | a2018annualshareholdermeet.htm |
| 2018-04-26 | 8-K/A | 2018-04-25 | 2.02 Results of Operations and Financial Condition | 2.02 On April 25, 2018, Core Laboratories N.V. issued a press release announcing its financial results for the first quarter of 2018. | q12018earningsrelease8-ka.htm |
| 2018-04-26 | 8-K | 2018-04-25 | 7.01 Regulation FD Disclosure | clb-2018q1_earningsrelease.htm | |
| 2018-04-17 | 8-K | 2018-04-17 | 7.01 Regulation FD Disclosure | 7.01 On April 17, 2018, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on April 27, 2018 and payable May 22, 2018. | clb-8k_dividend2q2018.htm |
| 2018-01-31 | 8-K | 2018-01-31 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 2.02 On January 31, 2018, Core Laboratories N.V. issued a press release announcing its financial results for the fourth quarter of 2017 and full year ended December 31, 2017. 5.02 On January 31, 2018, the Company announced that, effective at the conclusion of the 2018 annual shareholders’ meeting (the “Annual Meeting”), Richard Bergmark will resign from his role as Chief Financial Officer and he will not seek re-election to the Supervisory Board of Directors of the Company (the “Supervisory Board”). | clb-2017q4_earningsrelease.htm |
| 2018-01-16 | 8-K | 2018-01-16 | 7.01 Regulation FD Disclosure | 7.01 On January 16, 2018, Core Laboratories N.V. issued a press release announcing a quarterly cash dividend of $0.55 per share of common stock for shareholders of record on January 26, 2018 and payable February 16, 2018. | clb-8k_dividend1q2018.htm |